Bioavailability of Two Oral Formulations of Clopidogrel: A Randomized, Open Label, Single Dose, Two-Period, Crossover Comparison in Healthy Mexican Volunteers.

Trial Profile

Bioavailability of Two Oral Formulations of Clopidogrel: A Randomized, Open Label, Single Dose, Two-Period, Crossover Comparison in Healthy Mexican Volunteers.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 08 Oct 2011

At a glance

  • Drugs Clopidogrel (Primary)
  • Indications Thrombosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 08 Oct 2011 New trial record
    • 06 Oct 2011 Actual initiation date changed from Jul 2008 to May 2008 as reported by ClinicalTrials.gov.
    • 06 Oct 2011 Planned end date changed from 1 Oct 2008 to Aug 2008 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top